Kansas City Business Journal editor Brian Kaberline published an opinion piece in the May 20, 2016 edition of the paper: “Editor’s Notebook: Aratana’s success could change KC’s perception.”
News and Events
At the Intersection of Human Science and Veterinary Medicine, Aratana Therapeutics is continuing its mission of bringing new therapeutics to help raise the standard of care for pets.
The human and animal connection is deeper than just the bond we have with our pets and that our pets have with us – the similarities are in our DNA and how our biological systems function.
Today the Company announced the U.S. Food and Drug Administration’s Center for Veterinary Medicine (CVM) approved NOCITA® (bupivacaine liposome injectable suspension) as a local post-operative analgesia for cranial cruciate ligament surgery in dogs.
Solutions For Unmet Needs
Pets are our passion
because pets are family
The relationship between people and pets is closer than ever before. This deep bond has created a demand for therapeutics for pets as advanced as those for human members of the family. Aratana is uniquely positioned to quickly deliver new solutions to veterinarians for unmet or underserved medical needs of your patients. We’re passionate about providing innovative solutions.Read More